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In a selected group of human immunodeficiency virus 
(HIV)-infected patients we confinn the expansion of a 
COS+ T-Iymphocyte subset, Le. , the CD8+/Leu7+ cells, 
which account for 300/0 ofthe Iymphocytes, compared to 3% 
in the control donors. In addition, a e08+ T-Iymphocyte 
suhset that coexpresses dass 11 (DR) antigens, Le., COS·,., 
DR+ cells, is also increased from 1.5% in controls to 27% in 
the HIV-infected patients. Using three<olor immunoftuo-
rescence and flow cytometry we can demonstrate that the 
CD8+/Leu7+ and the CD8+/class 11+ cells are not distinct 
hut overlapping suhsets. In the HIV-infected patients 42% 
ofthe CD8+/Leu7 + celJs were strongly positive for class TI 
and these CD8+lLeu7+/ciass 11+ ceUs accounted for l3%of 
aillymphocytes. These findings indicate that the expanded 
CD8+ lLeu?+ cells are activated and hence might be actively 
involved in immune defense in acquired immune deficiency 
syndrome (AIDS). 
KEY WORDS: Acquired immune deficiency syndrome (AIDS); 
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INTRODUCTION 
Detailed studies on the lymphocyte subsets in hu-
man immunodeficiency virus (HIV)8 infection have 
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reveaJed that, in addition to depletion of CD4 Iym-
phocytes, the CD8 cells can be expanded, both in 
percentage and in absolute numbers (2-7). The most 
prominent feature evolving from two-color immu-
nofluorescence analysis of the CD8+ cells in these 
studies was the expansion of a usuaJly minor subset 
of CD8+fLeu7+ cells and, in addition, in some 
patients of CD8+/c1ass n + cells (2, 8). Thus far it 
remained unclear whether these two populations 
are separate regulatory elements evolving in the 
course of the disease or whether class n is ex-
pressed on the CD8+ /Leu7+ cells in these patients, 
We have approached this question by using three-
color fluorescence analysis in flow cytometry. Dur 
studies show that, in fact, CD8+/Leur and CD8+/ 
class 1I+ are not distinct but are overlapping popu-
lations , i.e., dass 11 is expressed on the CD8+/ 
Leu7+ cells, suggesting that these cells are actively 
involved in the immunoregulatory events in AIDS. 
MATERIALS AND METHons 
Patients and Controls 
The group of 10 patients studied consisted of 
eight male homosexuals and two male hemophiliacs 
with a mean age of 37 years. All were HIV seropo-
sitive, seven had AIDS according to the Centers of 
Disease Contro) Classification, two patients had 
ARC, and Olle patient was apparently healthy 
(Table I). CytomegaJovirus (CMV) carrier status 
was demonstrated in eight of eight patients. In 
seven of seven no CMV -specific IgM antibody was 
detectable. At the time of sampling, none of the 
patients had acute disease, except for patient 2, 
who exhibited local Herpes simplex virus 2 (HSV-2) 
infection. None of the patients received antimicro-
T.able I, Lymphocyte Subseis in 10 Patients wilh H1V lnfecl ion 
Patient No, Clink a! slaging" Co.' COS u.7 T4/1'8 ralio 
pcp, AIDS 4.0 74.1 58.2 0.1 
(77) (1429) ( 11 22) 
2 KS, AIDS 2 .0 61.6 33. 1 0 
(24) (729) (391) 
3 CE, AIDS 18 .0 53.8 3M 0.3 
(523) (1564) (1058) 
4 KS, AIDS 11.0 45.0 3U 0.2 
(326) (1331) (933) 
5 ARC 18.0 % .7 23.3 0.4 
(324) (84(1) (420) 
6 CE, AIDS 9.0 68.' 33 .3 0. 1 (95) (725) (350) 
7 ARC 19.0 II I 37.\ 0.3 
(357) (1036) (697) , PCP, AIDS 5.0 66.0 60.7 0.1 
(109) (1432) (131 8) 
9 PCP, AIDS 0 62.4 49.5 0 
(0) (779) (618) 
10 Heallhy 6 .0 51.2 31.7 0.1 
(41) (348) (21 6) 
Mean ~ SO 9. 2 ± 7.0· 58.5 :!: 9.7· 39.5 j: 12.4· 0.2 , 0. 1" 
(188 ± 179)" (1021 :!: 401)· (712 , 3n)" 
Mean j: SO of 
controls (N "" 11 ) 31.4 
" 
tU 16.0 :!: 4.5 15.8 , ' .3 2.1 , LI (748 
" 
314) (392 :!: 189) (374 , 206) 
· CE, candidiasis of esophagus ; PCP, Pneumocystls corinii pncumonia; ARC, AIDS-relalcd complex ; KS , Kaposi's sarcoma. 
~Values are given as percenlages of aIJ Iymphocytes (cells/mm' ). 
· P .:s 0.001. 
" P .:s 0.02. 
biallrealment and none received cylotox.ic therapy. 
The I t control donors (mean age, 30 years; all male) 
were apparently healthy volunteers. 
Isolation 0/ Mononuclear Cells 
Heparinized blood was taken for routine diagno--
sis and PBM were isolated by FicoLl-Hypaque 
density-gradient separation (I); aliquots were 
stored in liquid nitrogen after controlled freezing. 
Sampies for the preseot study were selected based 
on high percentages of CD8 Iymphocytes. 
Absolute leukocyte counts and differential counts 
were obtained from EDTA blood sampies according 
to routine hematological procedures. 
For immunoftuorescence analysis cells were 
thawed rapidly in a 37°C water bath. After washing 
lW cells per sampie were incubated for 30 min at 
4°C with saturating concentrations of a mixture of 
the monoclonaJ antibodies (MAß) Leu2a-phy-
coerythrin, Leu7-fluorescein (bOlh Becton Dickin-
son) , and either L243-biotin (anti-dass 11 purified 
from the supernatant of the respective hybridoma) 
or M-T9tO-biotin CD2, kindly provided by E. P. 
Rieber, Munich. After two washes cells were incu-
bated with avidin Texas red (Mcdac, Hamburg, 
F.R.G.) for 30 min at 4°C, and after final washes 
they were fixed with 1% paraformaldehyde. lmmu-
notluorescence for T4 was done with Tl51 MAB in 
the first and goat anti-mouse IgFITC ([ago, Bur-
Iingame, CA) in the second step. 
Flow CYlomelry 
Analysis was done on an EPICS 753 (Coulter 
ElecLronics. Krefeld, F.R.G.) equipped with an 
argon laser (300 mW) for 488-nm excitation and 
with a dye laser (Coherent 599) containing rho-
damine 6G, pumped with all Iines from a second 
argon laser (3 W) to generate the - 600-nm excita-
tion . The intersections of the 488- and 600-nm laser 
beams with the liquid stream were set 7 ~sec apart. 
The 488-nm scattered light was used for determina-
tion of the forward-angle light scatler (FALS) and 
9<r light scaUer (90% LS) properties and signal 
processing was triggered by FALS. Ninety-degree 
LS signals were directed to the 9<r LS photomulti-
plier tube (pMT) using a 488-nm long-pass dicroic 
mirror. The passing light was blocked with an 
additional 457- to S02-nm laser btocking filter . 
Green ftuorescent light was directed with a 550-nm 
long-pass dicroic mirror to the green P~ff equipped 
with a 525-nm band-pass filter. The red and yellow 
fluorescent light passing the 550-nm long-pass di-
croie mirror was then split by a 6OO-nm short-pass 
dicroic mirror that reftected the red fluorescent light 
to the red PMT cquipped wit h a 635-nm band-pass 
and a 61O-nm long-pass filter. The yellow fluores-
cent light passing the 6QO-nm mirror reached the 
yellow PMT, wh ich was equipped with a 575-nm 
band-pass plus a 55O-nm long-pass filter. 
To control for spectral overlap and for proper 
temporal correlation of signals , control beads 
(Texas red , 1/ 16 bright) were used. TR beads gave 
red signals only (calibrated to channel 130 on the 
256-channel scale). The 1/16 bright beads (Coulter 
Electronics) gave green plus yellow staining (cal i-
brated to channel 190 each). 
Analys is was done gated on Iymphocytes and at 
least 40,000 cells were analyzed per sampie with log 
amplification. Evaluation of acquired histograms 
was done using a SAM 6S K computer (KWS, 
Ettlingen, F.R.G.) with software written by P. 
Rohwer, Erl angen, F.R.G. 
Percentages of positive cells were determined by 
setting cursors around distinct populations such as 
CDS and Leu7 or they were determined by using a 
subtract program (Coulter Electronics) for ftuores-
cence distributions that overlap with the isotype 
control staining, as is the case for class Il. Absolute 
cell counts from the respcctive populations were 
determined by multiplying the absolute Iymphocytc 
count by percentagesl lOO. Fluorescence intensity is 
expressed as the mean channel that marks the 
inlensity leve l at wh ich 50% of the cells are to the 
right. The mean specific fluorescence intensity is 
the mean channel of specific staining minus the 
mean channel of staining with the isotype control. 
RESULTS 
All paticnts stud ied had percentages of CD4'" 
Iymphocytes ranging from 0 to 20% and all but one 
had absolute C04+ Iymphocyte counts of less than 
360/mm3 (Table I). Thc CDS'" Iymphocytes in abso-
lute numbers were increased, with more than 600 
cells/mm3 in 9 of 10 patients and normal in I, but in 
percentages they were always increased, with an 
average of 59%. The resulting CD4/CDS ratio there-
fore was abnormal in evcry patient, with values of 
0.1 or less in six patients (Table I). The Leu7 '" cell s 
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Ag. I. Ellpansian of CD8"'/Leu7~ and CD8+IDR" cells in a 
patient with HIV inreetion. Shown are two-colar immunofluo-
rescence plots, always giving C0 8 staining on the y axis . The x 
axis gives Leu7 staining (A, B) or DR staining (C, 0). Sampies 
from a eontrol donar are in A and C: those from a patient (Na. 
10) in B and O. The patient exhibits 20.8% (D8 '/Leu7+ cells and 
35.3% ( D8+fDR" cells , compared 10 ].2% and 2.6%, respec· 
tively, ror the control donar. 
showed a pattern similar to that of COS+ cells, with 
increased values of more than 600/mm3 in 6 of 10 
patients. 
Analysis of the expression of the Leu7 and thc 
DR antigens on the COS+ cell s confinned the ex-
pansion of both the CDS"'/Leu7'" and the CDS"'I 
DR '" cells (Fig. 1). In this example 21% of the 
lymphocytes were CD8+/Leu7'" and 35% were 
CD8 ... /DR ... . In the ent ire group of HI V-infectcd 
patients, CDS"'/Leu7+ accounted for 28%, com-
pared to 3% for the controls (Table ll). The CDS"'I 
DR'" cells were 25% in the patients and 1.5% in the 
controls. Since in the patients stud ied, the sum of 
CDS+/DR+ ceUs is less or onl y a fcw percent higher 
than the total number of CDS'" Iymphocytes, it is 
possible that the Iwo double-stained ceU popula-
tions are, by far and large, mutually exclusive, 
distinct Iymphocyte subsets. Alternatively, they 
could represent overlapping populations. To ap-
proach thi s question we performed three-color im-
munoftuorcscence and we analyzed the expression 
Table 11_ Clau 11 Expression on Lymphocyte Subpopulations 
Class lI-positive cell!" 
Patient No. Clinical stagins" COS+1Leur d CDS"fDR'" CDS"!Leu7- CDS+fLcu7+ CD8 ILeu7 · 
PCP, AIDS 49.S 31.1 l4 36 
" (960) (600) 2 KS, AIDS 26.0 30.S l4 44 39 (308) (365) 
3 CE, AIDS 30.7 12.9 27 22 28 
(893) (375) 
4 KS, AIDS 16.4 22.0 
" 
39 29 (485) (652) , ARC 16.6 22.' l4 40 30 (299) (412) 
6 CE, AlDS 31.1 43.4 64 62 77 
(328) (457) 
7 ARC 29.7 14.9 39 17 52 
(559) (28<l) 
8 PCP, AIDS 40.1 ".8 41 33 21 
(869) (515) , PCP. AIDS 42.5 31.8 
" 
49 35 
(531) (397) 
10 Heahhy 20.8 35.3 64 76 
" (142) (240) Mean ± SD 30.4 ± 11.1 - 26.9 ± 9.4- 50.7 , 11 .8- 41.S ::t; 17.5- 42.0 , 17.3· 
(537 ± 28!W (429 :!: I3W 
Mean ±. SD of 
controls (N - 11) 2.7 ± 1.8 1.5 , 1.0 7.1 , 4.8 16.7 ± 6.8 7.0 , 7. 1 
(70 :!: 58) (38 , 31) 
· Values Me given as percentages of aillymphocytes (cellslmml ). 
·Values are given as percentages of the specified subpopulalion. 
~CE, candidiasis of esophagusi PCP, pnellmocyst;s carinii pneumonia; ARe, AIDS-reJated complex.; KS, Kllposi 's sarcoma. 
-P :s 0.001. 
ofDR antige ns on CDS+/Leu7- , CDS+fLeu7+. and 
CDS- fLeu7+ Iymphocyte subsets. 
As shown in Fig. 2 Ihere is a strong expression of 
DR antigens on aJl three subsets in the patient , 
while minimal staining is detected with the cells of 
the contro) donor. Staining with the CD2 MAß gave 
positive staining in the majority of cell s for both 
patient and control, as exemplified for the CDS+/ 
Leu7+ cells (Fig. 2). Data for the entire group of 
patients are compi led in Table 11 , whic h indicates 
that for a ll patients increased DR expression can be 
observed on all three subsets. The average percent-
age of DR+ ceUs among the CDS+/Leu7+ cells was 
42% for the patients and 17% for the controls. 
Taking into account. however. the low represcnta-
tion of CD8+ /Leur ce lls, with 1.5% in the contro! 
group (Table ll) , the triple-stained celJs amount to 
only 0.4%. in contrast to about 13% in the patients. 
Further support fo r the minor significance of DR 
antigen expression on CDS+ Iymphocytes in 
healthy control donors comes from analysis of the 
specific ftuorescence intensity. which is reflective of 
antigen de nsity (Fig. 2). Whereas the patients' 
CD8+fLeu7+ cells exhibit a mean spccific ftuores-
cence inlensity corresponding to 24.0 channels. the 
control donors' cells have intensity values of only 
5.0 channels on the log scale. Thus compared with 
the weak expression of DR on a few CDS+/Leu7+ 
cell s in controls, the DR antigen density is eightfold 
higher in HIV-infected patients. 
DISCUSSION 
The majority of studies concerned with the im-
mune dysfunclion of HIV infection has focused on 
the CD4+ Iymphocyte since Ihi s ceJl appears 10 be 
the primary target cell of H1V infecLion. Less 
attention has been given to CDS+ Iymphocytes, 
although these cells might playa major role in the 
pathophys iology of HIV infection, be it as cells 
involved in protective immunity or as cells that 
further suppress immune reactivity. CDS+ Iympho-
cytes were found 10 be increased in the different 
stages of HIV infcclion in several reports (2-7). 
In patients with definite AIDS some studies re-
port a persistent increasc in absolute CDS+ num-
bers (7), while others report that CDS+ cells be-
come normal again (4) . Duc 10 the decrease in CD4+ 
Class 11 (DR) CD2 
Fig. 2. Expression of DR antigens on COS· cells in AIDS. Given is the ftuorcscence intensity (x axis) on a log scale 
VCrsllS the ccll number (y axis) for DR compared 10 Ihe isotype cantml for Ihe firsllhree panels. while in the fourth panel 
staining for CD2 is shown as the posit ive conlml . Thc upper row gives results (rom the conlrol donOf (average spedfic 
fluorescenee intensity for DR, 3.5 channels); the lowcr rQW gives results for the patient (No. 10; average specific 
fluorescence inlensity, 32.0 channtls). 
Iymphocytes in blood as weil as in Iymphatic tissue, 
the CD8+ cells, in any event, remain the predomi· 
nant population with progression of HIV infeellon. 
An expansion of circulating CD8+ cells is a eom· 
mon phenomcnon in various viral infections (4, 9). 
Using two-color immunoftuorescence ofCD8+ Iym· 
phocytes, HIV infection was specifically associated 
with an inc rease in the CD8+ ILeu7+ subset (4). 
CD8+/Leu7+ cells were increased in HJV·infected 
patients without symptoms, with ARC, and with 
AiDS (3-5, 7. 8). Moderate expansions of the 
CD8+/Leu7+ cells were also reported for other 
disease states involving the immune system, i.e ., in 
common variable immunodeficicncy (10) and after 
bone marrow transplantation (11). In addition. 
some healthy CMV carriers exhibit increased 
CD8+/Leu7+ cells (12). 
As 10 the function of CD8+/Leu7 + cells, one 
study could demonstrate cytotoxic activity (13) , 
while in another study suggestive evidence sup-
ported suppressor acti vity (14). In patients with 
allogeneic bone ffiarrow transplantation CD8+ / 
Leu7+ cells were shown 10 exert supprcssor-cell 
activity for B-ccll differentiation (11). The CD8+/ 
Leu7+ cells, however, are not NK cells, sißce the 
latter express low-dcnsit y CD8 (15), while as also 
demonstrable in Fig. 2, thc CD8+/Leur and the 
CD8+IDR+ cells are high-intensity CD8 cells. Fur-
thermore, functiooal studies in patients with high 
CD8+/Leu7 + numbers rcvealed decreased NK-cell 
activity (3). 
Thus far, it is unclear whether the CD8+/Leu7+ 
cells in AIDS are functionaJly active at all or 
whether they represent cell s that are accumulated 
due to a blockade in differentiation. Human T 
Iymphocytes upon activation express class 11 mol-
ecules on their su rface. Incidentall y, CD81ympho-
cyles were fouod 10 express increascd dass 11 in a 
large proportion (50-60%) ofpaticnts with ARC and 
AIDS but not in seronegativc homosexuals (2, 8, 16; 
Stachel er al., unpublished). 
In thc present study of a group of patients sc-
lected for high CD8 percentages. we found in-
creased CD8+/Leu7+ and C08+/DR+ cells in every 
sampie. The percentages of these two populations 
frequen tl y add up to less than the total C08 per· 
centage or they exceed this figure slightly. Hence 
( WO possibilities can be di scussed. 
(I) CD8'+ lLeu7+ cells and CD8+ IDR + cells are, by 
fa r and large, lwo separate cell populations. 
(2) CD8+Il.eu7+ cells overlap with the C08+/ 
DR+ cclls, i.e., CD8+/Leu7+ cells are DR 
positive. 
Our studies using three-color immunofluoresc-
ence cJearly demonslrate that the CD8+/Leu7+ cells 
in HJV-infected palients do e)tpress DR antigens. 
This is in contrast to results in otherwise healthy 
patients with CMV-camer status, where no in-
crcase in DR antigens on T cells were detected (12). 
None of the HJV-seropositive patients but one 
had c1inical evidence of active infection e)tcept for 
infection with HIV and none received specific treat-
ment at the time of study. While a role of other 
agents causing latent and inapparent infeclion can-
not be excluded, the possibility might be considered 
that the induction of DR antigens on the CD8+/ 
Leu7+ cells is a direct result of HIV infection of the 
patients. Furthermore, since DR e)tpression on T 
Iymphocytes goes along with Iymphocyte activa-
tion, we suggest that the CD8+/Leu7+ cells are 
activated in the course of HIV infection and might 
be actively involved in mechanisms of immune 
defense in AIDS. 
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